La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
M1 Kliniken Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Attila Strauss
Amministratore delegato
n/a
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | 1.8yrs |
Proprietà del CEO | n/a |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | 1.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28AMMINISTRATORE DELEGATO
Attila Strauss
1.8yrs
Mandato
Mr. Attila Strauss is Member of Management Board & Chief Executive Officer of M1 Kliniken AG since November 24, 2022 and March 2023 respectively. He studied International Trade Management (B.A.) and Inform...
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Member of Supervisory Board | 9.2yrs | Nessun dato | Nessun dato | |
Chairman of Supervisory Board | 1.8yrs | Nessun dato | Nessun dato | |
Deputy Chairman of Supervisory Board | 1.8yrs | Nessun dato | Nessun dato |
1.8yrs
Durata media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di M12 non è considerato esperto (durata media del mandato 1.8 anni), il che suggerisce un nuovo consiglio.